What is the Calithera Biosciences Inc. stock price forecast?

Calithera Biosciences Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Calithera Biosciences Inc. insider trading activity?

View the latest insider trading data for Calithera Biosciences Inc. on Alpha Lenz.

What is Calithera Biosciences Inc.'s P/E ratio?

View Calithera Biosciences Inc.'s valuation metrics on Alpha Lenz.

Calithera Biosciences Inc.

NASDAQ · CALA

$0.00

Ask about Calithera Biosciences Inc.'s future dividend policy...

Alpha Chat Insight

“Calithera Biosciences Inc.'s ROE is -275.6%. Explore profitability and growth together.”

Ask for details →

Company Overview

Calithera Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule compounds, primarily in the field of tumor biology. Its primary function involves discovering and advancing therapeutic candidates that can potentially address various cancer-related challenges. The company operates within the biotechnology sector, specifically targeting precision oncology. Although it has transitioned into a plan of liquidation, historically, Calithera Biosciences Inc. contributed to advancements in cancer treatment through innovative small molecule therapies. Headquartered in South San Francisco, California, the company was founded in 2010 and played a role in shaping the landscape of cancer research.

CEODr. Susan M. Molineaux Ph.D.

Websitehttps://www.calithera.com

SectorFinancial Services

IndustryShell Companies

Employees8

Company Statistics

FY 2022

Profile

$1.39KMarket Cap

$0.00Revenue

0.00Shares Out

8Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

0.00P/B

N/AEV/Sales

0.54EV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-84.87%ROA

-275.60%ROE

-90.06%ROIC

Financial Health

$25.45MCash & Cash Equivalents

$-17.17MNet Debt

40.62%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Calithera Biosciences Inc.'s ROE is -275.6%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Calithera Biosciences Inc. (ticker: CALA) is a company listed on NASDAQ in the Financial Services sector (Shell Companies). It has approximately 8 employees. Market cap is $1,390.

The current price is $0 with a P/E ratio of -x and P/B of 0x.

ROE is -275.60%.